13 completed, 5 unknown, 2 recruiting, 1 withdrawn. 21 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 21 | Completed 13, Unknown 5, Recruiting 2, Withdrawn 1 |
Follow Vaccination: new trials by email Literature Review of Vaccination trials Research Report on Vaccination
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients RSVPreF3 vaccination - Vaccination, Respiratory Syncytial Virus (RSV) | Phase 4 | Recruiting | Seoul National University Hospital | 80 | 2026-10-01 | 2026-10-26 |
| Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons Serogroup B meningococal vaccine - Meningococcal Meningitis, Serogroup B, Transgender Persons | Phase 4 | Recruiting | University Ghent | 250 | 2025-01-31 | 2026-01-20 |
| PFAS Exposure and Immune Response to Vaccination in Adults TENIVAC - Innate Inflammatory Response, Vaccination | Phase 4 | Completed | Rutgers, The State University of New Jersey | 20 | 2024-11-04 | 2025-12-30 |
| Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis HAVRIX - Cirrhosis, Hep A | Phase 4 | Unknown | Mahidol University | 50 | 2024-02-29 | 2024-03-19 |
| Cost-effectiveness of the Influenza Vaccination Quadrivalent Influenza Vaccine - Influenza Vaccine, Cost-Effectiveness | Phase 4 | Unknown | International Centre for Diarrhoeal Disease Research, Bangladesh | 2567 | 2022-09-29 | 2023-08-18 |
| A Clinical Trial to Evaluate the Immunogenicity and Safety of PPV23 Vaccine Revaccinations in the Elderly 23-valent pneumococcal polysaccharide vaccine - Vaccination | Phase 4 | Completed | China National Biotec Group Company Limited | 331 | 2021-03-30 | 2022-02-16 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old 23-valent pneumococcal polysaccharide vaccine - Vaccination | Phase 4 | Completed | China National Biotec Group Company Limited | 330 | 2021-03-21 | 2022-02-16 |
| Evaluation of the Safety and Immunogenicity of Hepatitis A Vaccine Hepatitis A (Live) Vaccine, Freeze-dried produced by Changchun, Hepatitis A (Live) Vaccine, Freeze-dried produced by Zhejiang, Hepatitis A (Live) Vaccine, Freeze-dried produced by the Institute of Medical Biology, CAMS - Vaccination | Phase 4 | Unknown | China National Biotec Group Company Limited | 450 | 2020-11-12 | 2021-02-26 |
| Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA sIPV+DTaP+HepA, sIPV, DTaP - Vaccination | Phase 4 | Unknown | China National Biotec Group Company Limited | 600 | 2020-11-11 | 2020-11-19 |
| Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP Sabin-IPV and DTaP, Sabin-IPV, DTaP - Vaccination | Phase 4 | Completed | China National Biotec Group Company Limited | 702 | 2019-08-16 | 2022-07-07 |
| Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP Sabin-IPV and DTaP, Sabin-IPV, DTaP - Vaccination | Phase 4 | Unknown | China National Biotec Group Company Limited | 702 | 2019-08-10 | 2019-08-12 |
| Immunogenicity and Safety of Sabin-IPV Replacement Vaccination Inactivated Polio Vaccine - Vaccination | Phase 4 | Completed | China National Biotec Group Company Limited | 360 | 2018-03-01 | 2020-09-09 |
| To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPV Sabin-IPV+bOPV+bOPV, Sabin-IPV+Sabin-IPV+bOPV, Sabin-IPV+Sabin-IPV+Sabin-IPV - Vaccination, Reaction - Vaccine | Phase 4 | Completed | China National Biotec Group Company Limited | 604 | 2018-03-01 | 2019-08-13 |
| Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls Fluenz Tetra (The two groups are defined by immunisation history, all receive the same intervention in the study) - Influenza Vaccination, Influenza | Phase 4 | Completed | Public Health England | 373 | 2017-10-02 | 2019-08-28 |
| Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B 4CMenB Vaccine - Prematurity, Vaccination | Phase 4 | Completed | St George's, University of London | 136 | 2017-08-01 | 2020-12-01 |
| Special Access Program IMVAMUNE® IMVAMUNE® - Vaccination | Phase 4 | Completed | Bavarian Nordic | 22 | 2010-04-22 | 2020-08-19 |
| Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Have to be Vaccinated MenBVac® MenBVac Vaccination - Vaccination | Phase 4 | Completed | University Hospital, Rouen | 218 | 2009-04-01 | 2026-06-12 |
| Efficacy of Influenza Vaccine in HIV Infected Adults MUTAGRIP - HIV, Influenza | Phase 4 | Completed | University of Witwatersrand, South Africa | 507 | 2008-04-01 | 2008-10-09 |
| A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix Menitorix (MenC and Hib conjugate) - Vaccination | Phase 4 | Completed | Public Health England | 30 | 2007-07-01 | 2019-03-22 |
| Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections Engerix-B - Hepatitis B, Vaccination | Phase 4 | Completed | Laval University | 1129 | 1995-09-01 | 2013-05-29 |
Showing 20 of 21. Sign in to see all of them.
Influenza, Human (3) · Coitus (1) · Diphtheria (1) · Fibrosis (1) · HIV Infections (1) · Hepatitis A (1) · Hepatitis B (1) · Inflammation (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Premature Birth (1) · Tetanus (1)
Infections (8) · Virus Diseases (5) · RNA Virus Infections (4) · Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Orthomyxoviridae Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Blood-Borne Infections (2) · Communicable Diseases (2) · Digestive System Diseases (2) · Gram-Negative Bacterial Infections (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Liver Diseases (2)
23-valent pneumococcal capsular polysaccharide vaccine (2) · 4CMenB vaccine (2) · Hepatitis A Vaccines (2) · 10-valent pneumococcal conjugate vaccine (1) · 13-valent pneumococcal vaccine (1) · Cell Adhesion Molecules (1) · Diphtheria-Tetanus Vaccine (1) · Engerix-B (1) · Freeze Drying (1) · Influenza Vaccines (1) · PHiD-CV vaccine (1) · Poliovirus Vaccine, Inactivated (1) · Tetanus Toxoid (1) · Vaccines (1) · mutagrip (1)
China National Biotec Group Company Limited (8) · Public Health England (3) · Bavarian Nordic (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · Laval University (1) · Mahidol University (1) · Rutgers, The State University of New Jersey (1) · Seoul National University Hospital (1) · St George's, University of London (1) · University Ghent (1) · University Hospital, Rouen (1) · University of Witwatersrand, South Africa (1)
China (8) · United Kingdom (4) · United States (2) · Bangladesh (1) · Belgium (1) · Canada (1) · France (1) · South Africa (1) · South Korea (1) · Thailand (1)
Elizabeth Coates, PhD (2) · Bernard Duval, MD (1) · Ed Kaczmarski, MBBS (1) · Fenyang Tang (1) · Gary Fujimoto, MD (1) · Ian Sanne, MBBCh (1) · Jiang WU (1) · Nam Joong Kim, M.D., PhD. (1) · Paul Heath, MBBS (1) · Prof. Dr. Isabel Leroux-Roels, PhD, MD (1) · Qianli Ma (1) · Robert Laumbach, MD (1) · Shabir A Madhi, MBBCH PhD (1) · Shaobai Shaobai (1)
PMID 10439494, PMID 10471173, PMID 10618544, PMID 11855555, PMID 15195237, PMID 15750456, PMID 16372666, PMID 16708058, PMID 18425905, PMID 19683086, PMID 20532100, PMID 21148531, PMID 21806398, PMID 21820477, PMID 22271960, PMID 22658929, PMID 23206974, PMID 23210147, PMID 23581957, PMID 23732900, PMID 23830973, PMID 23974637, PMID 24055351, PMID 24750586, PMID 24791735, PMID 25902573, PMID 26336905, PMID 26842617, PMID 27646030, PMID 27746226, PMID 27980374, PMID 28506297, PMID 28507927, PMID 28623028, PMID 28867508, PMID 28887164, PMID 29024434, PMID 29063064, PMID 29100706, PMID 29197154, PMID 29197174, PMID 29232882, PMID 29388197, PMID 30144521, PMID 30471956, PMID 30715348, PMID 30793097, PMID 31642899, PMID 32747216, PMID 33110280
2017 (1)